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Abstract Liver progenitor (oval) cells have enormous potential in the treatment of patients with liver disease using a cell
therapy approach, but their use is limited by their scarcity and the number of donor livers from which they can be derived. Bone
marrow may be a suitable source. Previously the derivation of oval cells from bone marrow was examined in rodents using
hepatotoxins and partial hepatectomy to create liver damage. These protocols induce oval cell proliferation; however, they do
not produce the disease conditions that occur in humans. In this study we have used the choline-deficient, ethionine-
supplemented (CDE) diet (which causes fatty liver) and viral hepatitis as models of chronic injury to evaluate the contribution of
bone marrow cells to oval cells under conditions that closely mimic human liver disease pathophysiology. Following
transplantation of lacZ-transgenic bone marrow cells into congenic mice, liver injury was induced and the movement of bone
marrow cells to the liver monitored. Bone marrow-derived oval cells were observed in response to the CDE diet and viral injury
but represented a minor fraction (0–1.6%) of the oval cell compartment, regardless of injury severity. In all situations only rare,
individual bone marrow-derived oval cells were observed. We hypothesized that the bone marrow cells may replenish oval cells
that are expended by protracted liver injury and regeneration; however, experiments involving a subsequent episode of chronic
liver injury failed to induce proliferation of the bone marrow-derived oval cells that appeared as a result of the first episode.
Bone marrow-derived hepatocytes were also observed in all injury models and controls at a frequency unrelated to that of oval
cells. We conclude that during viral-and steatosis-induced liver disease the contribution of bone marrow cells to hepatocytes,
either via oval cells or by independent mechanisms, is minimal and that the majority of oval cells responding to this injury are
sourced from the liver.
© 2008 Elsevier B.V. All rights reserved.Abbreviations: 2-AAF/PH, 2-acetylaminofluorene/partial hepatectomy; AST, aspartate aminotransferase; BM, bone marrow; BMT, bone
marrow transplant; CDE diet, choline-deficient, ethionine-supplemented diet; MHV, murine hepatitis virus.
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196 J.N. Tonkin et al.Introduction proliferation was induced by toxins that cause hepatocyteThe liver has a substantial capacity to regenerate, possessing
alternative repair mechanisms that involve various cell pop-
ulations, depending on the nature of the damage. Acute
damage is generally repaired through replication of existing
hepatocytes. However, when this response is inhibited,
which is often the case in chronic diseases, a compartment
of bipotential liver progenitor (oval) cells carries out reg-
neration (Farber, 1956, Fausto and Campbell, 2003). Recent
work has shown that hepatocytes can derive from bone
marrow (BM)(Farber, 1956) [CE2] cells in both rodents and
humans (Theise et al., 2000a,b Alison et al., 2000; Petersen
et al., 1999; Lagasse et al. 2000). The occurrence of such
cells in most models examined to date is too low to be of any
immediate functional benefit, although with selective pres-
sure these cells may expand to significant numbers, and this
pathway could constitute a third avenue of liver repair (Wang
et al., 2002).
Oval cells are a highly proliferative compartment of cells
that generate hepatocytes and cholangiocytes when normal
regenerative mechanisms are inhibited. Once activated,
they emerge from the periportal region, proliferate rapidly,
and migrate into the parenchyma, where they differentiate
and replace damaged tissue. Morphologically, they are small
and ovoid-shaped, with a high nuclear-to-cytoplasm ratio.
Antigenically, they express markers in common with fetal
and adult hepatocytes (α-feto-protein, M2 pyruvate kinase
(MPK), albumin) and cholangiocytes (cytokeratins 7 and 19)
(Golding et al., 1995; Tee et al., 1996). They also share a
number of markers with hematopoietic stem cells (Thy1,
Sca-1 CD34, stem cell factor, c-kit, Flt3, Flt3 ligand) (Omori
et al., 1997; Petersen et al., 2003). As oval cells are a transit-
amplifying compartment, they comprise proliferative cells
at various stages of lineage specification and are thus pheno-
typically heterogeneous, expressing combinations of markers
depending on their differentiation status and the conditions
used to induce them.
The cellular source of oval cells is difficult to determine,
as there is no oval cell-specific marker. Putative precursors
have been identified within the terminal bile ductules known
as the canals of Hering, in both humans and rodents (Theise
et al., 1999). More recently, the branching cords of oval cells
induced by 2-acetylaminofluorene/partial hepatectomy
(2-AAF/PH) were shown to connect directly to the canals,
providing strong evidence for a ductular origin of oval
cells (Paku et al., 2001). However, these findings are not
applicable to all models of oval cell proliferation, because in
the choline-deficient, ethionine-supplemented (CDE) diet
and allyl alcohol models, oval cells arise from a periductular
location (Yin et al., 1999). The oval cells in these models are
also less ductular in appearance than those in 2-AAF/PH,
further suggesting they may not be ductular in origin (Sell,
2001).
Reports that oval cells express several markers of
hematopoietic stem cells prompted a study by Petersen et
al. to investigate a developmental relationship between the
two cell types (Petersen et al., 1999). They found that a
minor subpopulation of oval cells was derived from BM;
however, other studies found the number of BM-derived oval
cells insignificant (Menthena et al., 2004; Vig et al., 2006;
Kanazawa and Verma, 2003). In these studies oval cellnecrosis or chemical agents that block hepatocyte replica-
tion combined with a proliferative stimulus such as partial
hepatectomy or carbon tetrachloride. These experimental
models induce large numbers of oval cells and are widely
used to study oval cell biology in rodents; however, they
are not representative of the human chronic liver disease
conditions.
In humans, oval cell reactions occur in chronic diseases,
including hepatitis B and C infection and alcoholic and
nonalcoholic fatty liver disease, conditions that often co-
occur (Libbrecht et al., 2000; Lowes et al., 1999). These are
different from the above-mentioned animal models and
involve steatosis, immune responses, and fibrosis, which
contribute to the disease etiology. Steatosis often accom-
panies viral-, alcohol-, and obesity-related hepatitis and it is
associated with the proliferation of hepatic progenitor cells
(Clouston et al., 2005). It is increasingly recognized as an
important cofactor in the development and progression of
preexisting liver disease (Williams, 2006; Powell et al.,
2005). A CDE diet is an alternative animal model of chronic
liver damage and oval cell induction with pathophysiology
similar to the human condition. Treated mice develop fatty
liver preventing hepatocyte replication, and long-term
treatment with the diet results in progressive fibrosis and
eventually hepatocellular carcinoma (Tee et al., 1996). In
this study we have used genetically tagged BM cells to
investigate their contribution to the oval cell pool in the CDE
diet and viral-mediated models of injury that more closely
reflect human liver disease conditions that involve chronic
injury accompanied by inflammation.
Results
Characterization of CDE diet and murine hepatitis
virus (MHV)-induced hepatitis
In two separate experiments we transplanted mice with
transgenic BM and then subjected them to the CDE diet to
induce chronic liver injury. In one of these experiments we
used mice that were naturally infected with MHV. These mice
were seropositive for MHV when tested 3weeks after the BM
transplant and all mice were positive for MHV by RT-PCR
analysis of liver tissue obtained at the time of sacrifice (data
not shown). This resulted in four experimental groups, which
were followed throughout a 6-week time course beginning at
initiation of the CDE diet (Fig. 1). We chose this time course
to follow the activation and expansion of the oval cell
compartment according to our experience with this model.
We first evaluated liver injury in the four experimental
models. Histologically, CDE-fed mice accumulated fat in the
liver after 3days on the diet, which was resolved by 2 or, at
the latest, 3weeks. This damage was associated with in-
flammation and the appearance of oval cells (Fig. 2C),
consistent with our previous experience with the diet
(Akhurst et al., 2001). Infection of C57Bl/6 mice with MHV
is often transient and subclinical in immunocompetent
animals, while young and immunosuppressed mice develop
a range of pathologies including hepatitis (Dupuy et al.,
1975). We have previously examined MHV-infected mice and
observed oval cell-mediated regenerative responses (Fig. 3).
Figure 1 Experimental outline of liver injury regimen. (A) Mice received BM transplants (BMT) to generate BM chimeras. Four weeks
after BMT half of the mice were fed a CDE diet to induce proliferation of oval cells, while the remaining mice were kept on normal
chow as controls. Additionally, a group of mice infected with MHV were treated with the same protocol. Thus in total there were four
experimental groups: controls, CDE diet, MHV-infected, and CDE diet+ MHV-infected. At 3, 7, 14, 21, and 42days post-initiation of the
CDE diet (t=0), groups of mice (n=3) were sacrificed and livers harvested for analysis. (B) Mice were subjected to two rounds of CDE
diet injury (n=4) to induce expansion of BM-derived oval cells that were seeded in the liver as a result of the initial injury.
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context of immunosuppression caused by irradiation-induced
myeloablation used to prepare mice for BM transplantation.
Accordingly, features of MHV histopathology were evident in
these animals, including extensive inflammation, syncytia
formation, and limited hepatocyte necrosis (Fig. 2E). Mice
that were both infected with MHV and fed the CDE diet
exhibited features of both injuries, but they were more
severely affected than those who sustained individual
injuries and showed steatosis, severe hepatic necrosis, and
lobular disarray (Fig. 2F).
We confirmed hepatocellular damage by increased serum
aminotransferases (AST) in all injury models. The AST levels
of CDE-fed mice with or without virus infection rose
markedly above control levels at 3 and 7days and then
returned to a normal level. The initial increase in AST was
1.7-fold higher in mice with both CDE diet and MHV-induced
injury, illustrating the synergistic combination of the two
types of injury in the progression of liver damage. Further-
more, MHV-infected mice had a moderate but consistent
elevation of AST above that of controls at all time points
(data not shown).
We assessed oval cell induction by positive immuno-
staining for three markers, A6, CK19, and MPK, in addition
to morphological criteria. Quantitation of the A6 cells is
presented (Fig. 4), and the trend was similar when we quan-
tified the oval cells using CK19 and MPK as markers. Oval cells
were present in all injury models (Figs. 2D, 2F, andFig22H). In
response to the CDE diet, periportal oval cells appeared by
3days and increased in numbers throughout the experiment.
MHV-infected animals also produced an oval cell response,
even in the absence of the CDE diet. Although there was large
interindividual variability, the number of oval cells remained
relatively constant throughout the 6-week time course. Thecombination of CDE diet and MHV infection induced sig-
nificantlymore oval cells than just the CDE diet (P=0.0007) or
MHV (P=0.0007), consistent with the increased level of
damage in this group.
MHV infection increases BM-derived cell infiltration
of the liver
To facilitate tracking of BM cells, we generated lacZ BM
chimeras in C57Bl/6 congenic mice that we then subjected to
liver injury. Flow-cytometric analysis of the CD45.2 alloanti-
gen confirmed stable engraftment of the BM averaging 91%
(range 84–98%). 4-Chloro-5-bromo-3-indoyl-β-D-galactopyra-
noside (X-gal)-stained liver cryosections showed increasing
infiltration of BM cells throughout the liver over time. Admi-
nistration of the CDE diet did not significantly increase the
number of BM cells directed to the liver; however, infection
with MHV dramatically increased infiltration, between four-
and eightfold, at all time points examined (Fig. 5). We judged
the majority of BM-derived cells in the livers of MHV-infected
mice to be primarily inflammatory, with an average 75% of
cells staining positively for both X-gal and CD45 (Fig. 6A).
A minor percentage of oval cells induced by the
CDE diet are BM derived
We identified oval cells originating from BM by X-gal staining
combined with A6 or CK19 immunohistochemistry. We ob-
served no significant difference (PN0.05) between the fre-
quencies of A6-and CK19-positive, BM-derived oval cells;
thus we present only the results obtained with A6.
We detected X-gal and A6 double-positive cells in all
injury models, though not in all livers examined. The per-
Figure 2 Liver damage and oval cell proliferation in mice fed a
CDE diet or infected with MHV. (A, C, E, G) Liver histology in
hematoxylin and eosin-stained sections at day 7. No signs of
pathology were evident in control livers (A), while the CDE diet-
fed mice accumulated fat and inflammatory cells (C). Significant
inflammation was present in MHV-infected mice and small
syncytia were observed (inset, E). Mice with both CDE diet and
MHV-induced injury developed more severe hepatitis (G). (B, D,
F, H) Oval cells were identified in liver sections by immunohis-
tochemistry for A6. Representative images from the 14-day time
point are shown. At day 14 A6 staining was mostly restricted to
the bile ducts in controls (B), while periportal oval cells were
observed in mice fed the CDE diet (D) or infected with MHV (F).
Significantly greater oval cell proliferation was apparent in mice
with both CDE diet and MHV-induced injury (H). Scale bars,
100μm.
Figure 3 MHV induces an oval cell response. Liver cryosec-
tions obtained from MHV-infected mice were immunohisto-
chemically stained with the oval cell marker A6 to assess oval
cell proliferation. Cell counts are presented compared to un-
infected controls. Data represent means ± SEM, n=7 for MHV
group, n=2 for controls.
198 J.N. Tonkin et al.centage of animals with X-gal and A6 double-positive cells in
each injury model was 73% for CDE, 70% for MHV, and 100% for
CDE+ MHV. These cells were located periportally, among
clusters of non-BM-derived oval cells. Interestingly, we never
observed X-gal-expressing oval cells adjacent to one ano-
ther; rather they were always observed as individual cells
within the clusters of X-gal-negative oval cells (Figs. 6B and
6C). BM-derived oval cells were extremely rare, representingonly 0–1.6% of the oval cell population. In 19% of animals
with liver injury we detected no BM-derived oval cells, while
12% of animals had greater than 1% of oval cells derived from
BM. The time point examined did not significantly affect this
frequency in all injury models (data not shown). In all models
there was a small increase in the absolute numbers of BM-
derived oval cells over time; however, this was not sig-
nificant (Fig. 7A). The absolute numbers of BM-derived oval
cells were similar in both CDE diet and MHV-induced injury
(0.015 and 0.036 cells per 100 hepatocytes, respectively);
interestingly, there were significantly more BM-derived oval
cells in the CDE+ MHV combined damage model (0.18 cells/
100 hepatocytes) compared to CDE diet (P=0.001) and MHV
(P=0.015) alone (Fig. 7A). The increased frequency of BM-
derived oval cells in the CDE+ MHV mice correlated with the
increased number of total oval cells, such that the propor-
tions of oval cells generated from BM were similar in CDE diet
(0.25%), MHV (0.67%), and CDE diet+ MHV (0.6%).
Further injury does not induce proliferation of
BM-derived oval cells
The previous results suggest that the contribution of BM-
derived oval cells to liver regeneration following chronic
injury is insignificant. However, one possibility we consid-
ered was that these cells may be activated in the endogenous
oval cell pool only after they had been integrated in the liver.
Thus we hypothesized that, with a subsequent insult, a BM-
derived oval cell response may be stimulated. To test this,
we subjected mice to two rounds of CDE-induced liver injury,
as depicted in Fig. 1B. We have previously shown that, fol-
lowing removal of the CDE diet, oval cells become quiescent
and begin to differentiate into small hepatocytes (Tee et al.,
1996; Knight et al., 2005). Thus by applying, removing, and
reapplying the CDE diet, we examined the contribution of
BM-derived cells to a second round of liver injury following
their integration in the liver.
Removal of the CDE diet significantly reduced numbers of
A6-positive oval cells (Pb0.05) as shown previously (Tee et
al., 1996; Knight et al., 2005) (Fig. 7C). Readministation of
the diet resulted in a second wave of oval cell proliferation,
comparable to the first. However, this reinjury did not induce
proliferation of BM-derived oval cells. As for the single-injury
experiments, we observed only individual lacZ/A6 double-
Figure 4 Quantification of oval cell proliferation in CDE, MHV, and CDE+ MHV models. A6-positive oval cells were quantified in four
experimental groups throughout the 6-week time course. A6-positive cells in the controls represent some of the bile duct cells that
could not be distinguished from oval cells in the injury models and so were included in the control counts to ensure accuracy of the
difference in oval cell numbers. The CDE diet and MHV infection generated oval cell responses of similar magnitudes, while the
combination of CDE+ MHV generated significantly more oval cells at all time points (P=0.0007; same P value for CDE diet and MHV).
Data represent means±SEM, n=2 for MHV group, n=3 for all other groups.
199Bone marrow cells in chronic liver regenerationpositive cells (Fig. 6D), and the proportion of oval cells that
were derived from the BM was unaltered in mice that
received continuous CDE feeding (0.019 cells/100 hepato-
cytes; 0.34% of total oval cells) compared to those that were
reinjured (0.018 cells/100 hepatocytes; 0.29% of total oval
cells) (Fig. 7D).
Contribution of BM-derived cells to hepatocytes and
cholangiocytes
We found BM-derived hepatocytes in control livers and all
injury models, distributed throughout the parenchyma, with
no apparent spatial relationship to BM-derived oval cells
(Fig. 6F). Control and CDE livers contained similar numbers of
BM-derived hepatocytes and the frequency was comparable
to that of BM-derived oval cells in CDE livers (0.033 cells/100
hepatocytes). In contrast, MHV infection strongly influencedFigure 5 BM cell infiltration of the liver is increased in MHV-infect
BM-derived cells by X-gal staining. Cells originating from BM were id
significantly more BM cells in the liver of MHV-infected mice compare
livers contained significantly more BM-derived cells than control (P=
between the MHV and the CDE+ MHV groups. Data represent means±the appearance of BM-derived hepatocytes; between 5-and
32-fold more were detected in MHV (0.42 cells/100
hepatocytes) or CDE+ MHV (0.30 cells/100 hepatocytes)
than in uninfected control (0.022 cells/100 hepatocytes) or
CDE (0.033 cells/100 hepatocytes) tissues (Fig. 7B).
We observed occasional BM-derived cholangiocytes in
CK19-stained sections, integrated into bile ducts (Fig. 6E).
They appeared in all the injury models and were not increased
as a result of viral injury, unlike BM-derived hepatocytes.
Discussion
In this study we have tracked BM cells to examine their
contribution to liver regeneration following chronic injury
induced by a CDE diet or viral hepatitis, in a novel model of
accelerated oval cell induction. Both simulate human liver
disease. BM cells generated oval cells in viral and steatosis-ed animals. Liver cryosections were analyzed for the presence of
entified by a blue-staining nucleus and quantified. There were
d to control (P=0.0002) and CDE (P=0.0109); similarly CDE+ MHV
0.001) and CDE (P=0.0009). There was no significant difference
SEM, n=2 for MHV group, n=3 for all other groups.
Figure 6 BM-derived cells produce oval cells, hepatocytes,
and cholangiocytes. The phenotype of BM-derived cells was
determined by X-gal staining combined with immunohistochem-
istry for cell-type-specific markers (A) CD45, hematopoietic
cells; (B, C) A6, oval cells; (D, E) CK19, oval cells and cholan-
giocytes; and (F) albumin, hepatocytes; in addition to morpho-
logical criteria. The majority of the BM-derived cells in the liver
were CD45 positive (A). Rare BM-derived oval cells were
observed positively stained for A6 (B) and CK19 (D). Only indi-
vidual BM-derived oval cells were seen. A second course of liver
injury failed to induce proliferation of the BM-derived oval cells,
which were still detected only as single cells within clusters of
non-BM-derived oval cells (D). BM-derived cholangiocytes (E)
and hepatocytes (F) were observed. Representative images are
shown, injury model, time point, and labeling antibody are in-
dicated. Scale bars, 100μm.
200 J.N. Tonkin et al.related liver disease but their contribution to the oval cell
compartment was minimal under these conditions, with a
frequency similar to that reported for other experimental
models (Petersen et al., 1999; Menthena et al., 2004, Wang
et al., 2003).
The CDE diet is commonly used to study oval cell biology
and successfully adapted by our laboratory for mice (Akhurst
et al., 2001). Prior to this study, the effects of immunosup-
pression and MHV infection on the oval cell response had not
been evaluated. Interestingly, infection with MHV elicited a
moderate oval cell response even in the absence of con-
current CDE feeding. Previous reports have shown that in-
fection with MHV is normally subclinical; however, immature
or immunosuppressed mice fail to eliminate the virus
and develop a range of pathologies from minimal damage
to chronic or fulminant hepatitis (Dupuy et al., 1975). Hepa-
tocellular damage results from the infection of hepatocytes,the deposition of fibrin, and thrombosis, similar to those
seen in human viral hepatitis (Marsden et al., 2003). For this
reason MHV is employed as an experimental model of viral
hepatitis (Marsden et al., 2003; Levy et al., 2003; Lamon-
tagne et al., 2001) and chronic viral hepatitis in immuno-
suppressed animals (Uetsuka et al., 1996). The C57Bl/6 mice
used in these experiments incurred moderate, prolonged
viral hepatitis, which included inflammation, hepatic necro-
sis, and an oval cell reaction. Oval cell proliferation has been
reported in murine cytomegalovirus infection (Cassell et al.,
1998) and in human viral hepatitis B and C (Libbrecht et al.,
2000; Eleazar et al., 2004); however, this is the first report of
MHV inducing a liver progenitor cell response.
Our results demonstrate that viral infection aggravates
CDE diet-induced damage and augments the oval cell
response. Further, the combination of CDE and MHV treat-
ments was significantly more effective than the sum of the
individual effects, suggesting synergy exists. A similar
phenomenon occurs in humans, in which hepatic steatosis
accelerates the pathogenesis of hepatitis C-induced liver
disease (Adinolfi et al., 2001; Powell et al., 2005). The MHV
and CDE diet models, alone or in combination, serve as an
interesting set of tools for examining liver disease, as they
share many pathological similarities with human diseases.
We detected A6-and CK19-positive, BM-derived oval cells
in all three conditions of liver injury. These cells appeared in
the liver continually, modestly increasing in numbers through-
out the injury time course. Their frequency correlated with
injury severity and also with the total number of oval cells (BM
and non-BM derived). Irrespective of the degree of liver
damage, these cells represented only a minor percentage of
all oval cells (range 0–1.6%), consistent with other liver injury
models (Menthena et al., 2004). Oval cells are highly
proliferative once activated, particularly in the first 2weeks
of the CDE time course (Knight et al., 2005). Curiously, the
BM-derived oval cells were observed exclusively as individual
cells, despite being located within clusters of expanding
endogenous oval cells. This suggests that the BM-derived oval
cells were quiescent, a result that concurs with the
observations of Menthena et al. (Menthena et al., 2004).
Furthermore, when the injury stimulus was withdrawn and
then reapplied, the contribution of BM cells did not change,
nor was proliferation of BM-derived oval cells induced. This
suggests that BM-derived oval cells do not respond to the
same proliferative signals as their endogenous counterparts.
It is possible that the BM-derived oval cells are a distinct
oval cell subpopulation that requires additional selective
pressure to proliferate. In a recent study, few BM-derived oval
cells were observed in the standard 2-AAF/PH model; how-
ever, administration of monocrotaline to block proliferation of
liver-resident oval cells resulted in proliferation of the BM-
derived oval cells such that they constituted 20% of the oval
cell compartment (Oh et al., 2007). Similarly expansion of BM-
derived hepatocytes occurs only when all other regenerative
mechanisms are ineffective (Mallet et al., 2002). In our
models, regeneration was accomplished by the endogenous
oval cells, as evidenced by an improvement in liver structure
and reduction of serum transaminases at the final time point.
As intrahepatic mechanisms were coping with regeneration,
involvement of BM oval cells may not be required.
We also assessed the formation of liver parenchymal cells,
hepatocytes, and cholangiocytes from BM. Interestingly, the
Figure 7 Quantification of BM-derived oval cells and hepatocytes. BM-derived oval cells identified in liver cryosections by positive
nuclear X-gal staining and immunostaining with A6 were quantified throughout a 6-week time course. BM-derived oval cells were
observed in all injury groups and increased over time. (A) Significantly higher numbers of BM-derived oval cells were observed in mice
receiving both CDE+ MHV injuries, correlating with the increased number of oval cells in this model. (B) Albumin-positive BM-derived
hepatocytes were present in all injury groups and controls, with greater numbers in MHV livers compared to control (P=0.0103) and
CDE (P=0.011) and in CDE+ MHV livers compared to control (P=0.0005) and CDE (P=0.0005). (C, D) In an attempt to induce
proliferation of BM-derived oval cells seeded in the liver, groups of mice (n=4) fed the CDE diet for 2weeks were given normal chow for
2weeks before being exposed to the CDE diet a second time to induce a second round of injury. Three control groups were included:
the “diet withdrawn” group was fed the CDE diet for 2weeks and then returned to normal chow for 4weeks, the “continuous CDE”
group was fed the CDE diet for 6weeks, and an uninjured “control” group was not fed the CDE diet. All mice were sacrificed at the 6-
week time point and analyzed for the proliferation of oval cells and BM-derived oval cells. The second round of injury induced a wave
of oval cell proliferation comparable to that of the first (C); however, this did not increase the number of BM-derived oval cells above
that of mice continuously receiving the diet (D). Data represent means±SEM, n=2 for MHV group, n=3 for other groups unless
otherwise indicated.
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202 J.N. Tonkin et al.only significant difference was between uninfected and MHV-
infected mice. Both groups showed a 10-fold elevation in the
number of BM-derived hepatocytes, compared to uninfected
animals. The CDE diet had no effect on this frequency, in
either infected or uninfected groups. Thus there was no
correlation between the numbers of BM-derived oval cells
and the appearance of BM-derived hepatocytes, suggesting
that at least some of the BM hepatocytes were not generated
by differentiation of BM-derived oval cells. Rather, they may
result from fusion between BM cells and hepatocytes; how-
ever, we were unable to assess this possibility in our model.
There is disagreement in the literature as to whether
injury promotes the appearance of new BM-derived hepato-
cytes (Wang et al., 2002;Vig et al., 2006; Quintana-
Bustamante et al., 2006; Korbling et al., 2002; Dahlke et
al., 2006). In our hands injury severity did not alter the
production of hepatocytes from BM; however, the type of
injury was important. Viral infection significantly increased
the infiltration of BM cells to the liver, and there was an
associated increase in the number of BM-derived hepato-
cytes. Increased liver infiltration of BM cells, caused either by
mobilization of BM cells (Quintana-Bustamante et al., 2006)
or immune-mediated hepatitis (Dahlke et al., 2006), has been
shown to increase the frequency of BM-derived hepatocytes.
In these studies the cells were generated by fusion, which has
previously been shown to occur between myelomonocytic
cells and hepatocytes (Willenbring et al., 2004). MHV injury
not only activates and recruits macrophages to the liver but
also causes fusion between hepatocytes and macrophages to
form syncytia. This could facilitate the production of BM-
derived hepatocytes and explain our results.
In looking for BM-derived CK19-positive oval cells we
occasionally observed double-positive cells forming bile
ducts. BM-derived cholangiocytes are seen in human livers
(Theise et al., 2000b) and in rodent models involving oval
cells (Petersen et al., 1999), while replacement of cholan-
giocytes in choleostatic disease occurs by self-replication
with no evidence of BM contribution (Moritoki et al., 2006).
Conclusion
BM-derived oval cells were produced in response to CDE diet
and also in mice with virally induced immune hepatitis; how-
ever, they represented only a minor proportion of the total
oval cell compartment. Even when liver was severely affected
by a combination of viral hepatitis and CDE diet the BM
contribution was minor. These cells were not involved in the
immediate response to liver injury or a subsequent episode of
injury and were not observed to proliferate at later time
points tested in the models used in this study, which closely
mimic human liver pathologies. These results confirm and
extend previous studies involving other models indicating that
the contribution of BM to the regenerative response to chronic
injury is small and unlikely to have any functional significance.
Materials and methods
Mouse strains and animal husbandry
H253 transgenic mice used as BM donors were a gift from
Seong Seng Tan (Howard Florey Institute, Melbourne, VIC,Australia). The H253 line is on a C57Bl/6 background and
carries an X-linked Escherichia coli lacZ reporter gene driven
by the promoter of 3-hydroxy-3-methylglutaryl coenzyme A
reductase linked to an SV40 T-antigen nucleus localization
signal sequence (Tam and Tan, 1992). The strain ubiquitously
expresses the lacZ gene in the cell nucleus. Pep3b B6 SJL/.
Ly5.1 (CD45.1) mice, congenic to C57Bl/6, were purchased
from the Animal Resource Centre (ARC; Perth, WA, Australia)
and used as transplant recipients. Animals were housed in
quarantine at ARC or at the preclinical facility at the Uni-
versity of Western Australia. All procedures were conducted
in accordance with the guidelines of the National Health and
Medical Research Council Australian code of practice.
Bone marrow transplants
Eight-week-old Pep3b B6 SJL/.Ly5.1 (CD45.1) mice were
lethally irradiated with two 5.5-Gy doses of γ-irradiation
from a 137Cs source (Gammacell 3000 Elan; MDS Nordion,
Kanata, ON, Canada) separated by a 4-h interval. Two hours
following irradiation, mice were transplanted with 2million
unfractionated bone marrow cells in 100μl of phosphate-
buffered saline (PBS) via the retro-orbital plexus. Mice were
maintained on antibiotic water containing 1.1g/L neomycin
sulfate (Sigma) and 1000 U/L polymyxin B sulfate (Sigma) for
1week prior to irradiation and 2weeks postirradiation. Donor
bone marrow was obtained from age-matched male H253
(CD45.2) transgenic mice. Bone marrow was flushed from
femurs and tibiae with PBS, washed, and resuspended in PBS
at a concentration of 2×107 cells/ml. Cells were kept on ice
until reconstitution.
Flow-cytometric analysis of bone marrow
engraftment
Hematopoietic chimerism was determined by analysis of BM
at the time of sacrifice. BM was collected, red cells were
lysed in 0.144M ammonium chloride, and nucleated cells
were stained with a CD45.2-FITC antibody (clone 104; Phar-
mingen, San Diego, CA, USA) in PBS+ 2% FCS. The proportion
of viable (propidium iodide negative) cells positive for the
donor CD45.2 allele was determined using Beckman Coulter
XL-MCL 4-Color Running System II version 3.0 analysis
software.
Chronic liver injury
Animals receiving BM transplants were allowed to recover for
4weeks and were then fed a CDE diet administered as
choline-deficient chow and drinking water supplemented
with 0.175% ethionine as previously described (Akhurst et
al., 2001). Control mice received transplants and remained
on normal chow and drinking water. In one experiment the
mice were naturally infected with murine hepatitis virus. All
mice were positive for MHV by RT-PCR of liver tissue. The
H253 strain was cesarean rederived to specific-pathogen-
free status for a second experiment, which was performed
identically to the initial experiment but in the absence of
MHV infection, which was confirmed by serology testing.
Consequently animals were divided into four treatment
groups: control, CDE, MHV, and CDE+ MHV. Mice were sacri-
203Bone marrow cells in chronic liver regenerationficed 3, 7, 14, 21, and 42days post-initiation of the CDE diet
as depicted in Fig. 1.
Histology and immunohistochemistry
For histology, portions of liver were fixed in Carnoy's solution
(60% ethanol, 30% chloroform, 10% glacial acetic acid) for 2h
at room temperature and then processed and embedded in
paraffin. Deparaffinized sections (5μm) were stained with
hematoxylin and eosin using standard techniques.
Immunohistochemistry was performed on frozen sections.
Liver pieces embedded in Cryomatrix (Shandon, UK) were
frozen in liquid nitrogen and stored at −80°C. Ten-micro-
meter cryosections were air-dried for 1h at room tempera-
ture and then fixed in methanol:acetone 1:1 for 3min.
Alternatively, to detect BM cells in the liver and determine
their phenotype, liver cryosections were first X-gal stained to
identify β-galactosidase-expressing BM cells and then immu-
nohistochemically stained with cell-type-specific markers.
For this, air-dried cryosections 15μm in thickness were fixed
for 2min in 0.2% glutaraldehyde, rinsed in PBS, and then
stained for β-galactosidase for 20h at 37°C (5mM potassium
ferricyanide, 5mM potassium ferrocyanide, 5mM MgCl2,
0.02% NP-40, 0.01% sodium dodecyl sulfate, 1mg/ml X-gal
in DMF, 20mM Tris, pH 7.3, in 0.1M phosphate buffer, pH 7.3).
X-gal-stained sections were washed in PBS and then immu-
nohistochemically stained as follows. Sections were
immersed in 3% H2O2 to block endogenous peroxidases and
then incubated with 10% fetal bovine serum to block
nonspecific binding of antibodies. Primary antibodies were
applied overnight at 4°C at the following dilutions: A6 (1:30;
gift from Valentina Factor, Bethesda, MD, USA), anti-mouse
CK19 (1:100; gift from Rolf Kemler, Freiburg, Germany), anti-
mouse albumin (1:200; ICN Biomedicals), and anti-mouse
CD45 (clone 30 F11, 1:150; BD Pharmingen). The sections
were washed three times in PBS and then incubated in
horseradish peroxidase-conjugated goat anti-rat IgG (1:80;
Amersham Biosciences) or sheep anti-rabbit IgG (1:200;
Sanofi Pasteur) for 1h at room temperature. After a final
three washes peroxidase activity was detected with liquid
DAB (DAKO) and then the sections were dehydrated and
mounted in DePex. Images were captured using an Olympus
DP11 camera attached to an Olympus CH40 microscope.
Cells were quantified by counting positively stained cells
in 10 to 20 fields of view (40× objective). Numbers of BM-
derived oval cells, hepatocytes, and inflammatory cells were
obtained by counting cells positive for A6, albumin, and
CD45, respectively, that also contained X-gal-positive nuclei.
Counts are expressed as the percentage of positively stained
cells that were also stained with X-gal or the average number
of double-positive cells per 100 hepatocytes.
MHV RT-PCR
Total RNA was isolated from liver tissue using TRIzol (Gibco
BRL) according to the manufacturer's instructions. One micro-
gram of RNA was reverse transcribed to cDNA with oligo(dT)
primers using the Thermoscript RT-PCR System (Invitrogen).
The cDNA was amplified using MHV-specific primers designed
by Homberger and colleagues (Homberger et al., 1991)
(forward primer, 5′-CAGCCTGCCTCTACTGTAAAACC-3′; reverse
primer, 3′-GCCTCCAAAATTCTGATTGGGGC-5′).Serum aspartate aminotransferase
Serum AST levels were determined using the GO-transami-
nase kit (Sigma Diagnostics) according to the manufacturer's
instructions.
Statistics
The data represent the mean averages±SEM. Statistical sig-
nificance was determined using two-way ANOVA or t test
with Pb0.05 indicating a significant difference. Analyses
were performed using PRISM (GraphPad).
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